{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:18:11Z","timestamp":1779387491531,"version":"3.53.1"},"reference-count":36,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,6,14]]},"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Recent treatment developments for HIV, hepatitis C virus (HCV) and hepatitis B virus (HBV) have greatly improved prognoses. Current screening practices are mainly risk based and are suboptimal. Improved efforts are critically needed to identify persons with these viruses. The aims of this study were to assess the feasibility of an opt-out bloodborne virus (BBV) screening programme in an acute medical unit (AMU) and to describe the prevalence of HIV, HBV and HCV in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and setting<\/jats:title>\n                    <jats:p>This was a cross-sectional observational study in the AMU of a tertiary referral hospital in Galway, a city in the west of Ireland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>1936 patients entered the study; 54% were male, mean age was 53.1 years (SD 19.6). During the study period, all patients attending the AMU aged \u226716 years who were having bloods drawn and who had the ability to verbally consent for an additional blood sample met the inclusion criteria for the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over 44 weeks, 1936\/4793 (40.4%) patients consented to BBV panel testing. Diagnosed prevalence rates for HIV, HBV and HCV were 0.5\/1000, 2\/1000 and 1.5\/1000, respectively. There was one HIV-positive result; the patient was already engaged in care. Four patients tested positive for HBV surface antigen; one new diagnosis, one previously lost to follow-up and two already engaged in care. Three patients had active HCV infection; two had been lost to follow-up and are now linked back into services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>BBV testing uptake of 40.4% is higher than previous studies in AMU settings that used opt-in strategies, but lower than expected, possibly due to not incorporating testing into routine practice. The diagnosed prevalence of HBV is notable as little data currently exist about its prevalence in Ireland. These data are valuable in order to inform further prevention strategies for these infections in low-prevalence settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-022777","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T06:04:01Z","timestamp":1563343441000},"page":"e022777","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Opt-out bloodborne virus screening: a cross-sectional observational study in an acute medical unit"],"prefix":"10.1136","volume":"9","author":[{"given":"Niamh","family":"Allen","sequence":"first","affiliation":[{"name":"Infectious Diseases, St James' Hospital, Dublin, Ireland"},{"name":"Infectious Diseases, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collette","family":"Faherty","sequence":"additional","affiliation":[{"name":"Microbiolgy\/ Virology, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Davies","sequence":"additional","affiliation":[{"name":"Acute Medicine Unit, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lyons","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarent","family":"Scarry","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Bohan Keane","sequence":"additional","affiliation":[{"name":"Hepatology, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Boyle","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"O\u2019Connell","sequence":"additional","affiliation":[{"name":"Infectious Disease, University Hospital Limerick, Dooradoyle, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eithne","family":"McCarthy","sequence":"additional","affiliation":[{"name":"Microbiology, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirbhile","family":"Keady","sequence":"additional","affiliation":[{"name":"Microbiology, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Bergin","sequence":"additional","affiliation":[{"name":"Department of Genitourinary and Infectious Diseases, St. James\u2019s Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lee","sequence":"additional","affiliation":[{"name":"Hepatology, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Fleming","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gallagher","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Galway University Hospitals, Galway, Ireland"},{"name":"Acute Medicine Unit, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Tuite","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Galway University Hospitals, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"key":"2025121509302250000_9.7.e022777.1","unstructured":"World Health Organisation. Fact sheet no: 360 HIV\/ AIDSS. 2015 www.who.int\/mediacentre\/factsheets\/fs360\/en (Accessed Mar 2019)."},{"key":"2025121509302250000_9.7.e022777.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01563.x"},{"key":"2025121509302250000_9.7.e022777.3","unstructured":"Health Protection Surveillance Centre. HIV in Ireland 2016 report. http:\/\/www.hpsc.ie\/a-z\/hivstis\/hivandaids (Accessed Nov 2018)."},{"key":"2025121509302250000_9.7.e022777.4","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(17)30183-2","article-title":"U=U taking off in 2017","volume":"4","author":"The Lancet Hiv","year":"2017","journal-title":"Lancet HIV"},{"key":"2025121509302250000_9.7.e022777.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600693"},{"key":"2025121509302250000_9.7.e022777.6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150546","article-title":"Opt-out panel testing for HIV, Hepatitis B and Hepatitis C in an urban emergency department: a pilot study","volume":"11","author":"O\u2019Connell","year":"2016","journal-title":"PLoS One"},{"key":"2025121509302250000_9.7.e022777.7","unstructured":"Health Protection Surveillance Centre (HPSC). Hepatitis B report 2015. http:\/\/www.hpsc.ie\/a-z\/hepatitis\/hepatitisb\/hepatitisbreports\/hepatitisannualreports\/ (Accessed Nov 2018)."},{"key":"2025121509302250000_9.7.e022777.8","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v4.i3.74"},{"key":"2025121509302250000_9.7.e022777.9","unstructured":"WHO. Global health observatory Data HIV\/AIDS. http:\/\/www.who.int\/gho\/hiv\/en\/ (Accessed Mar 2019)."},{"key":"2025121509302250000_9.7.e022777.10","unstructured":"ECDC. HIV and AIDs annual epidemiological report. 2016 https:\/\/ecdc.europa.eu\/en\/publications-data\/hivaids-annual-epidemiological-report-2016-2014-data (Accessed Nov 2018)."},{"key":"2025121509302250000_9.7.e022777.11","first-page":"199-202","article-title":"Patients accessing ambulatory care for HIV-infection: epidemiology and prevalence assessment","volume":"108","author":"Tuite","year":"2015","journal-title":"Ir Med J"},{"key":"2025121509302250000_9.7.e022777.12","unstructured":"Public Health England. National HIV testing week report. 2013 https:\/\/www.gov.uk\/government\/news\/phe-supporting-national-hiv-testing-week (Accessed Mar 2019)."},{"key":"2025121509302250000_9.7.e022777.13","unstructured":"ECDC. Special report; continuum of HIV care. 2017 https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/Continuum-of-HIV-care-2017.pdf (Accessed Mar 2019)."},{"key":"2025121509302250000_9.7.e022777.14","unstructured":"UNAIDS. 90\/90\/90 \u2013 An Ambitious Treatment Target to help end the AIDS epidemic. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/90-90-90_en.pdf (Accessed Mar 2019)."},{"key":"2025121509302250000_9.7.e022777.15","unstructured":"CDC. Morbidity and mortality weekly report, August 11th, 2006. https:\/\/www.cdc.gov\/mmwr\/index2017.html (Accessed Mar 2019)."},{"key":"2025121509302250000_9.7.e022777.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506816"},{"key":"2025121509302250000_9.7.e022777.17","unstructured":"Wilson JM , Jungner G . Principles and practice of screening for disease. Geneva, Switzerland: World Health Organization, 1968."},{"key":"2025121509302250000_9.7.e022777.18","first-page":"63","article-title":"Universal HIV testing by junior doctors: challenges in its implementation","volume":"13","author":"Tuite","year":"2012","journal-title":"HIV Medicine"},{"key":"2025121509302250000_9.7.e022777.19","unstructured":"British HIV Association (BHIVA). UK National guidelines for HIV testing, 2008. https:\/\/www.bhiva.org\/HIV-testing-guidelines (accessed March 2018)."},{"key":"2025121509302250000_9.7.e022777.20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00007435-199007000-00002","article-title":"Human immunodeficiency virus infection in women attending an inner-city prenatal clinic: ineffectiveness of targeted screening","volume":"17","author":"Barbacci","year":"1990","journal-title":"Sex Transm Dis"},{"key":"2025121509302250000_9.7.e022777.21","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.81.5.619"},{"key":"2025121509302250000_9.7.e022777.22","first-page":"678","article-title":"Determinants of acceptance of routine voluntary human immunodeficiency virus testing in an inner-city prenatal population","volume":"78","author":"Lindsay","year":"1991","journal-title":"Obstet Gynecol"},{"key":"2025121509302250000_9.7.e022777.23","unstructured":"Health Protection Surveillance Centre. HCV in Ireland 2016 Report. http:\/\/www.hpsc.ie\/a-z\/hepatitis\/hepatitisc\/hepatitiscreports\/hepatitisannualreports\/ (Accessed Nov 2018)."},{"key":"2025121509302250000_9.7.e022777.24","unstructured":"Hepatitis C Screening. National clinical guideline. 2017 https:\/\/health.gov.ie\/wp-content\/uploads\/2017\/08\/HepC-NCG-15_Summary_v8.pdf"},{"key":"2025121509302250000_9.7.e022777.25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2468-1253(17)30045-6","article-title":"Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study","volume":"2","author":"Razavi","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025121509302250000_9.7.e022777.26","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268811001920"},{"key":"2025121509302250000_9.7.e022777.27","unstructured":"ICORN. Strategic plan 2014-2018. https:\/\/www.icorn.org\/sites\/default\/files\/mediaroom\/icorn_strategic_plan_2014-2018.pdf"},{"key":"2025121509302250000_9.7.e022777.28","unstructured":"Health Service Executive. Primary care reimbursement services 2013. https:\/\/www.hse.ie\/eng\/staff\/pcrs\/pcrs-publications\/pcrs-statistical-analyis-of-claims-and-payments-2013.pdf (Accessed Mar 2019)."},{"key":"2025121509302250000_9.7.e022777.29","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1017\/S0950268817001947","article-title":"Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU\/EEA: a systematic review","volume":"145","author":"Hofstraat","year":"2017","journal-title":"Epidemiol Infect"},{"key":"2025121509302250000_9.7.e022777.30","unstructured":"European Centre for Disease Control (ECDC). Annual epidemiological report 2014 \u2013 sexually transmitted infections including HIV and blood-borne viruses. https:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/sexually-transmited-infections-HIV-AIDS-blood-borne-annual-epi-report-2014.pdf (Accessed Mar 2019)."},{"key":"2025121509302250000_9.7.e022777.31","unstructured":"Central for Disease Control. Recommendations for routine testing and follow-up for chronic hepatitis B Virus (HBV) Infection. https:\/\/www.cdc.gov\/hepatitis\/hbv\/PDFs\/ChronicHepBTestingFlwUp.pdf (Accessed Mar 2019)."},{"key":"2025121509302250000_9.7.e022777.32","unstructured":"HPSE. Infectious disease assessment for migrants 2015. https:\/\/www.hpsc.ie\/a-z\/specificpopulations\/migrants\/guidance\/File,14742,en.pdf (Accessed Mar 2019)."},{"key":"2025121509302250000_9.7.e022777.33","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp16X685225"},{"key":"2025121509302250000_9.7.e022777.34","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050401"},{"key":"2025121509302250000_9.7.e022777.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa042657"},{"key":"2025121509302250000_9.7.e022777.36","doi-asserted-by":"publisher","DOI":"10.1037\/a0016395"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-022777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:30:28Z","timestamp":1765819828000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-022777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,16]]},"published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1136\/bmjopen-2018-022777"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-022777","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}